Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,276 | 46 | 97.5% |
| Education | $33.22 | 2 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $410.43 | 14 | $0 (2020) |
| Fresenius USA Marketing, Inc. | $225.45 | 11 | $0 (2023) |
| BAXTER HEALTHCARE | $135.72 | 1 | $0 (2019) |
| Amgen Inc. | $125.00 | 1 | $0 (2022) |
| Relypsa, Inc. | $96.79 | 2 | $0 (2020) |
| Calliditas Therapeutics US Inc. | $84.29 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $59.40 | 3 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $46.20 | 3 | $0 (2023) |
| GlaxoSmithKline, LLC. | $44.80 | 3 | $0 (2024) |
| Bard Peripheral Vascular, Inc. | $38.17 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60.96 | 3 | Novartis Pharmaceuticals Corporation ($46.48) |
| 2023 | $237.69 | 13 | Fresenius USA Marketing, Inc. ($115.35) |
| 2022 | $260.82 | 8 | Amgen Inc. ($125.00) |
| 2021 | $38.17 | 2 | Bard Peripheral Vascular, Inc. ($38.17) |
| 2020 | $310.58 | 10 | AstraZeneca Pharmaceuticals LP ($228.64) |
| 2019 | $317.51 | 6 | AstraZeneca Pharmaceuticals LP ($181.79) |
| 2018 | $68.49 | 5 | Fresenius USA Marketing, Inc. ($45.29) |
| 2017 | $14.85 | 1 | Relypsa, Inc. ($14.85) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.61 | General |
| 02/26/2024 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug), BENLYSTA | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: NEPHROLOGY | ||||||
| 02/01/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $24.87 | General |
| 12/22/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $24.99 | General |
| 11/29/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Education | Cash or cash equivalent | $13.60 | General |
| Category: Nephrology | ||||||
| 10/11/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $12.92 | General |
| 09/27/2023 | GlaxoSmithKline, LLC. | JESDUVROQ (Drug), BENLYSTA | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: NEPHROLOGY | ||||||
| 09/05/2023 | Fresenius USA Marketing, Inc. | — | Food and Beverage | In-kind items and services | $17.46 | General |
| 08/30/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Phosphate binder for ESRD | ||||||
| 05/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $19.62 | General |
| Category: Cardio-renal | ||||||
| 03/23/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/08/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Nephrology | ||||||
| 01/17/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: IMMUNOLOGY | ||||||
| 01/13/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/29/2022 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Nephrology | ||||||
| 11/23/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Phosphate binder for ESRD | ||||||
| 09/28/2022 | Amgen Inc. | Tavneos (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Not Applicable | ||||||
| 07/13/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/05/2022 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Nephrology | ||||||
| 04/18/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/23/2022 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: Nephrology | ||||||
| 05/01/2021 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 447 | 943 | $441,317 | $170,286 |
| 2022 | 12 | 557 | 914 | $326,193 | $119,979 |
| 2021 | 13 | 523 | 1,080 | $517,402 | $202,202 |
| 2020 | 14 | 602 | 1,061 | $409,501 | $152,913 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 50 | 380 | $300,200 | $119,425 | 39.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 150 | 274 | $47,676 | $19,129 | 40.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 55 | 57 | $16,302 | $6,579 | 40.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 26 | $17,160 | $6,417 | 37.4% |
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Facility | 2023 | 26 | 26 | $16,640 | $5,333 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 54 | $16,092 | $4,724 | 29.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 34 | 44 | $6,952 | $2,736 | 39.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 21 | $5,502 | $2,253 | 40.9% |
| 36901 | Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | Facility | 2023 | 15 | 15 | $6,735 | $2,159 | 32.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 17 | $7,072 | $1,218 | 17.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 29 | 29 | $986.00 | $314.07 | 31.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 46 | 197 | $160,162 | $63,233 | 39.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 190 | 338 | $53,800 | $21,409 | 39.8% |
| 36902 | Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | Facility | 2022 | 47 | 53 | $34,291 | $11,022 | 32.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 46 | 48 | $14,328 | $5,497 | 38.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 49 | 68 | $10,972 | $4,368 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 45 | $13,617 | $3,459 | 25.4% |
| 36901 | Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | Facility | 2022 | 20 | 22 | $9,988 | $3,141 | 31.4% |
| 36907 | Balloon dilation of dialysis segment with review by radiologist | Facility | 2022 | 19 | 23 | $9,016 | $2,905 | 32.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 15 | 21 | $4,788 | $1,915 | 40.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 14 | $5,899 | $1,474 | 25.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 21 | 24 | $7,197 | $886.79 | 12.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 55 | 61 | $2,135 | $668.63 | 31.3% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 55 | 441 | $354,567 | $144,298 | 40.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 127 | 217 | $34,376 | $13,933 | 40.5% |
About Dr. Monte Wu, MD
Dr. Monte Wu, MD is a Nephrology healthcare provider based in Berkeley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902903578.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Monte Wu, MD has received a total of $1,309 in payments from pharmaceutical and medical device companies, with $60.96 received in 2024. These payments were reported across 48 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,276).
As a Medicare-enrolled provider, Wu has provided services to 2,129 Medicare beneficiaries, totaling 3,998 services with total Medicare billing of $645,380. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Berkeley, CA
- Active Since 09/17/2006
- Last Updated 08/10/2018
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1902903578
Products in Payments
- LOKELMA (Drug) $410.43
- Velphoro (Drug) $183.00
- Renal - PD (Device) $135.72
- Tavneos (Drug) $125.00
- Veltassa (Drug) $96.79
- TARPEYO (Drug) $84.29
- ACTHAR (Biological) $46.20
- JESDUVROQ (Drug) $28.82
- Auryxia (Drug) $23.20
- Kerendia (Drug) $19.62
- COVERA (Device) $17.58
- BENLYSTA (Biological) $15.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Berkeley
Dr. Lynda Anne Szczech, M.d, M.D
Nephrology — Payments: $47,001
Dr. Bryan Wong, Md, MD
Nephrology — Payments: $9,158
Dr. Josie Tebben, Md, MD
Nephrology — Payments: $3,755
Claudia Iota-Herbei
Nephrology — Payments: $2,170
Dr. Oliver Khakmahd, Md, MD
Nephrology — Payments: $1,053
Maria Pagtalunan, Md, MD
Nephrology — Payments: $902.66